Question 1

What is the catalog number for FBXL8 (F-Box/LRR-Repeat Protein 8, F-Box and Leucine-Rich Repeat Protein 8)?

Accepted Answer

The catalog number for FBXL8 (F-Box/LRR-Repeat Protein 8, F-Box and Leucine-Rich Repeat Protein 8) is 480890.

Question 2

What sizes are available for FBXL8 (F-Box/LRR-Repeat Protein 8, F-Box and Leucine-Rich Repeat Protein 8)?

Accepted Answer

FBXL8 (F-Box/LRR-Repeat Protein 8, F-Box and Leucine-Rich Repeat Protein 8) is available in the following size(s): 100 µL.

Question 3

Is FBXL8 (F-Box/LRR-Repeat Protein 8, F-Box and Leucine-Rich Repeat Protein 8) in stock?

Accepted Answer

FBXL8 (F-Box/LRR-Repeat Protein 8, F-Box and Leucine-Rich Repeat Protein 8) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

FBXL8 (F-Box/LRR-Repeat Protein 8, F-Box and Leucine-Rich Repeat Protein 8)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Cdk1 / p34cdc2 Serine-Threonine Kinase (A17.1.1), 0.2mg/mL

CA19-9 (Sialyl Lewis A) (121SLE), 0.2mg/mL

Anti-MEKK3/MAP3K3 Antibody Picoband®, Cy3 Conjugate

Hexokinase II Recombinant Rabbit Monoclonal Antibody [PSH07-97]

Anti-LONRF1 Antibody Picoband®, HRP Conjugate

MST4 Recombinant Rabbit Monoclonal Antibody [JE64-64]